ESR1 and breast carcinoma: In our previous work, we found that DHEA at the concentration of 10 μM exerted anti-proliferative effects in estrogen receptor-positive MCF-7 breast cancer cells without affecting the cell viability of normal mammary epithelial MCF-10A cells [32].